Zolpidem is an insomnia drug found in commonly-prescribed sleep medications, such as Ambien and Edluar.
In January, the FDA initially recommended that the public lower bedtime doses. Blood levels in some patients showed enough of the drug remaining in the morning to impair activities.
More Articles on Anesthesia:
ASA Launches Response to FDA’s Approval of SEDASYS Sedation System
Masimo Releases Clinical Studies at International Anesthesia Research Society Meeting
Physician Office Partners Develops Anesthesia Billing Solution
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.